Triasima Portfolio Management inc. Increases Stock Holdings in Cameco Corporation $CCJ

Triasima Portfolio Management inc. increased its holdings in Cameco Corporation (NYSE:CCJ) (TSE:CCO) by 168.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 106,764 shares of the basic materials company’s stock after purchasing an additional 67,064 shares during the period. Cameco accounts for 1.5% of Triasima Portfolio Management inc.’s investment portfolio, making the stock its 22nd biggest position. Triasima Portfolio Management inc.’s holdings in Cameco were worth $9,789,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Bison Wealth LLC grew its position in Cameco by 16.1% during the fourth quarter. Bison Wealth LLC now owns 21,448 shares of the basic materials company’s stock valued at $1,102,000 after acquiring an additional 2,975 shares during the period. AQR Capital Management LLC grew its position in Cameco by 16.6% during the first quarter. AQR Capital Management LLC now owns 9,547 shares of the basic materials company’s stock valued at $393,000 after acquiring an additional 1,361 shares during the period. Integrated Wealth Concepts LLC grew its position in Cameco by 48.7% during the first quarter. Integrated Wealth Concepts LLC now owns 8,485 shares of the basic materials company’s stock valued at $349,000 after acquiring an additional 2,780 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Cameco by 11.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 604,841 shares of the basic materials company’s stock valued at $24,895,000 after acquiring an additional 64,512 shares during the period. Finally, NewGen Equity Long Short Fund purchased a new stake in Cameco during the second quarter valued at about $14,252,000. Hedge funds and other institutional investors own 70.21% of the company’s stock.

Cameco Price Performance

Shares of NYSE CCJ opened at $120.39 on Monday. Cameco Corporation has a 1-year low of $45.42 and a 1-year high of $135.24. The business has a 50-day moving average of $114.95 and a 200-day moving average of $105.37. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.47 and a quick ratio of 1.68. The company has a market capitalization of $52.44 billion, a price-to-earnings ratio of 124.12, a PEG ratio of 2.05 and a beta of 1.04.

Cameco (NYSE:CCJ) (TSE:CCO) last issued its earnings results on Friday, February 13th. The basic materials company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.07. Cameco had a return on equity of 9.35% and a net margin of 17.00%.The company had revenue of $874.57 million during the quarter, compared to the consensus estimate of $782.13 million. During the same quarter in the prior year, the business earned $0.36 earnings per share. The company’s revenue was up 1.5% compared to the same quarter last year. On average, equities analysts anticipate that Cameco Corporation will post 1.3 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Royal Bank Of Canada boosted their price target on Cameco from $150.00 to $160.00 and gave the company an “outperform” rating in a research report on Tuesday, February 17th. Raymond James Financial reissued an “outperform” rating on shares of Cameco in a research report on Wednesday, January 14th. Glj Research reissued a “buy” rating and set a $171.20 price target (up from $100.00) on shares of Cameco in a research report on Wednesday, February 18th. The Goldman Sachs Group reissued a “buy” rating and set a $131.00 price target on shares of Cameco in a research report on Wednesday, February 4th. Finally, Canadian Imperial Bank of Commerce boosted their price target on Cameco to $202.00 in a research report on Monday, March 9th. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, Cameco has an average rating of “Moderate Buy” and a consensus target price of $150.40.

About Cameco

Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.